Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

aTYR PHARMA (ATYR) Leases (2019 - 2025)

aTYR PHARMA's Leases history spans 7 years, with the latest figure at $596000.0 for Q4 2025.

  • For Q4 2025, Leases fell 50.0% year-over-year to $596000.0; the TTM value through Dec 2025 reached $596000.0, down 50.0%, while the annual FY2025 figure was $596000.0, 50.0% down from the prior year.
  • Leases reached $596000.0 in Q4 2025 per ATYR's latest filing, down from $5.6 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $7.1 million in Q2 2023 to a low of $596000.0 in Q4 2025.
  • Average Leases over 5 years is $3.0 million, with a median of $1.5 million recorded in 2021.
  • Peak YoY movement for Leases: skyrocketed 786.98% in 2023, then crashed 82.61% in 2025.
  • A 5-year view of Leases shows it stood at $1.3 million in 2021, then fell by 1.5% to $1.2 million in 2022, then skyrocketed by 439.02% to $6.7 million in 2023, then tumbled by 82.28% to $1.2 million in 2024, then crashed by 50.0% to $596000.0 in 2025.
  • Per Business Quant, the three most recent readings for ATYR's Leases are $596000.0 (Q4 2025), $5.6 million (Q3 2025), and $894000.0 (Q2 2025).